Key result
A letter discussing a study on French registries from 1995 to 2015, noting that while in-hospital and 6-month mortality rates decreased over time, the reduction progressively declined in the past decade.
This letter highlights that while management of acute myocardial infarction has improved over 20 years, the mortality benefits have plateaued in the most recent decade.
We have read with interest the study by Puymirat et al1 updating the management and mortality data of patients with ST-segment–elevation myocardial infarction by using nationwide French registries 5 years apart from 1995 to 2015. The authors reported stable improvements in several variables, including time from symptom onset to hospital admission, use of mobile intensive care units, rates of reperfusion therapy, and more frequent use of primary percutaneous coronary intervention, and of antiplatelet and anticoagulant agents, as well. Overall, this has led to a consistent decrease of in-hospital and 6-month mortality rates over time. However, the burden of reduction in the rates of death progressively declined in the past decade, and were marginal (particularly among patients with non–ST-segment–elevation myocardial infarction) between 2010 and 2015.
No takes yet. Share an insight, caveat, or question.
Rodríguez-Granillo et al. (2018) conducted a letter in Acute Myocardial Infarction. A letter discussing a study on French registries from 1995 to 2015, noting that while in-hospital and 6-month mortality rates decreased over time, the reduction progressively declined in the past decade.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: